Treatment Groups | Doses (mg/kg) | pH | Specific gravity | RBC | Pus cell | Epithelial cell |
---|---|---|---|---|---|---|
Naïve | – | 7.22 ± 0.13b | 1.08 ± 0.08b | 1.10 ± 0.21b | 2.31 ± 0.21b | 1.55 ± 0.45b |
Control | – | 6.15 ± 0.21 | 1.41 ± 0.05 | 7.50 ± 1.10 | 14.45 ± 1.15 | 19.15 ± 1.16 |
APHMc | 100 | 6.55 ± 0.11a | 1.15 ± 0.10a | 3.08 ± 0.53a | 4.85 ± 0.25b | 5.58 ± 0.65b |
APHM | 200 | 6.85 ± 0.12a | 1.03 ± 0.01b | 1.55 ± 0.11b | 2.35 ± 0.55b | 2.88 ± 0.35b |
APHM | 300 | 7.04 ± 0.20b | 1.05 ± 0.02b | 1.11 ± 0.21b | 2.45 ± 0.54b | 1.44 ± 0.22b |
Silymarin | 100 | 7.12 ± 0.12b | 1.01 ± 0.05b | 2.0 ± 0.50b | 2.75 ± 0.75b | 4.56 ± 0.87b |